Evidence map›Paper›PMID 24871572›Full record

ArticleMolecules (Basel, Switzerland)2014

Anti-inflammatory and antipruritic effects of luteolin from Perilla (P. frutescens L.) leaves.

In Hwa Jeon, Hyeon Soo Kim, Hyun Ju Kang, Hyun-Seo Lee, Seung Il Jeong, Sang Jun Kim, Seon Il Jang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 131 citations in OpenAlex.

  1. Multi-Kingdom Synergy ofLife (Basel, Switzerland) · 2026
    Review
  2. Review
  3. The Anaphylactic and Anti-allergenic Properties of Shuanghuanglian: A Review.Combinatorial chemistry & high throughput screening · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Development of Polymeric Nanoparticles Loaded withInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. The Role and Mechanism ofMolecules (Basel, Switzerland) · 2023
    Review
  17. Article
  18. Applications ofAntioxidants (Basel, Switzerland) · 2023
    Review
  19. Article
  20. NovelPharmaceuticals (Basel, Switzerland) · 2022
    Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

In Hwa JeonAto Q&A Corporation, Jeonju 560-759, Korea. inflowerj@hanmail.net.
Hyeon Soo KimDepartment of Health & Science, Jeonju University, Jeonju 560-759, Korea. badaloves@naver.com.
Hyun Ju KangAto Q&A Corporation, Jeonju 560-759, Korea. dkgk0608@naver.com.
Hyun-Seo LeeDepartment of Health & Science, Jeonju University, Jeonju 560-759, Korea. jkll4903@hanmail.net.
Seung Il JeongJeonju Biomaterials Institute, Jeonju 561-360, Korea. siunite@hanmail.net.
Sang Jun KimJeonju Biomaterials Institute, Jeonju 561-360, Korea. biomale@hanmail.net.
Seon Il JangAto Q&A Corporation, Jeonju 560-759, Korea. sonjjang@jj.ac.kr.
Jeonju University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perilla (Perilla frutescens L.) leaves have shown therapeutic efficacy in the treatment of inflammatory disorders, allergies, bronchial asthma, and systemic damage due to free radicals. In the present study we analyzed the active constituents in perilla leaves using high-performance liquid chromatography (HPLC) and isolated luteolin, a polyphenolic flavonoid. We investigated the anti-inflammatory and antipruritic properties of luteolin. Luteolin inhibited the secretion of inflammatory cytokines such as interleukin-1β (IL-1 β) and tumor necrosis factor-α (TNF-α) from human mast cells (HMC-1) stimulated with phorbol myristate acetate plus calcium ionophore A23187 in a dose-dependent manner. Luteolin also significantly reduced the histamine release from rat peritoneal mast cells stimulated by compound 48/80, a potent histamine liberator. Furthermore, the administration of luteolin markedly inhibited the scratching behavior and vascular permeability induced by pruritogens, such as compound 48/80 or serotonin, in ICR mice. These results suggested that luteolin has potential as a therapeutic agent against inflammation and itch-related skin diseases.

Indexed as

AnimalsAnti-Inflammatory AgentsAntipruriticsCalcimycinHumansInterleukin-1betaLuteolinMaleMast CellsMiceMice, Inbred ICRPerillap-Methoxy-N-methylphenethylaminePruritusRatsRats, Sprague-DawleyAnti-Inflammatory AgentsAntipruriticsCalcimycinInterleukin-1betaLuteolinp-Methoxy-N-methylphenethylamineTetradecanoylphorbol AcetateTumor Necrosis Factor-alpha

Identifiers

PMID24871572
PMCPMC6271665
OpenAlexW1975314921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.